Format

Send to

Choose Destination
Haematologica. 2018 Jan;103(1):e39-e41. doi: 10.3324/haematol.2017.179150. Epub 2017 Nov 2.

Response to MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma.

Author information

1
Service and Central Laboratory of Hematology, University Hospital Lausanne (CHUV), Switzerland.
2
Institute of Pathology, University Hospital Lausanne (CHUV), Switzerland.
3
Department of Oncology, CHUV, University Hospital of Lausanne, Switzerland.
4
Service and Central Laboratory of Hematology, University Hospital Lausanne (CHUV), Switzerland sabine.blum@chuv.ch.

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center